Literature DB >> 18274553

TCTP protects from apoptotic cell death by antagonizing bax function.

L Susini1, S Besse, D Duflaut, A Lespagnol, C Beekman, G Fiucci, A R Atkinson, D Busso, P Poussin, J-C Marine, J-C Martinou, J Cavarelli, D Moras, R Amson, A Telerman.   

Abstract

Translationally controlled tumor protein (TCTP) is a potential target for cancer therapy. It functions as a growth regulating protein implicated in the TSC1-TSC2 -mTOR pathway or a guanine nucleotide dissociation inhibitor for the elongation factors EF1A and EF1Bbeta. Accumulating evidence indicates that TCTP also functions as an antiapoptotic protein, through a hitherto unknown mechanism. In keeping with this, we show here that loss of tctp expression in mice leads to increased spontaneous apoptosis during embryogenesis and causes lethality between E6.5 and E9.5. To gain further mechanistic insights into this apoptotic function, we solved and refined the crystal structure of human TCTP at 2.0 A resolution. We found a structural similarity between the H2-H3 helices of TCTP and the H5-H6 helices of Bax, which have been previously implicated in regulating the mitochondrial membrane permeability during apoptosis. By site-directed mutagenesis we establish the relevance of the H2-H3 helices in TCTP's antiapoptotic function. Finally, we show that TCTP antagonizes apoptosis by inserting into the mitochondrial membrane and inhibiting Bax dimerization. Together, these data therefore further confirm the antiapoptotic role of TCTP in vivo and provide new mechanistic insights into this key function of TCTP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274553     DOI: 10.1038/cdd.2008.18

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  69 in total

1.  Role of the translationally controlled tumor protein in DNA damage sensing and repair.

Authors:  Jie Zhang; Sonia M de Toledo; Badri N Pandey; Guozheng Guo; Debkumar Pain; Hong Li; Edouard I Azzam
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Authors:  D K Kim; B Y Nam; J J Li; J T Park; S H Lee; D H Kim; J Y Kim; H Y Kang; S H Han; T H Yoo; D S Han; S W Kang
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

3.  Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.

Authors:  Jie Lu; John S Kovach; Francis Johnson; Jeffrey Chiang; Richard Hodes; Russell Lonser; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

4.  Evolutionarily conserved binding of translationally controlled tumor protein to eukaryotic elongation factor 1B.

Authors:  Huiwen Wu; Weibin Gong; Xingzhe Yao; Jinfeng Wang; Sarah Perrett; Yingang Feng
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

5.  Translationally controlled tumor protein against apoptosis from 2-hydroxy-ethyl methacrylate in human dental pulp cells.

Authors:  Nattaporn Wanachottrakul; Wilaiwan Chotigeat; Ureporn Kedjarune-Leggat
Journal:  J Mater Sci Mater Med       Date:  2011-05-12       Impact factor: 3.896

6.  Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.

Authors:  Kerstin Krause; Susanne Prawitt; Markus Eszlinger; Christian Ihling; Andrea Sinz; Katrin Schierle; Oliver Gimm; Henning Dralle; Frank Steinert; Sien-Yi Sheu; Kurt W Schmid; Dagmar Fuhrer
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

7.  Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.

Authors:  Daiki Kobayashi; Mio Hirayama; Yoshihiro Komohara; Souhei Mizuguchi; Masayo Wilson Morifuji; Hironobu Ihn; Motohiro Takeya; Akira Kuramochi; Norie Araki
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

Review 8.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

9.  Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation.

Authors:  Zeyu Xiong; Yan Yan; Jian Song; Pu Fang; Ying Yin; Yu Yang; Alan Cowan; Hong Wang; Xiao-Feng Yang
Journal:  Atherosclerosis       Date:  2008-08-12       Impact factor: 5.162

10.  Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein.

Authors:  DI Wu; Ze Guo; Wei Min; Bingrong Zhou; Mingna Li; Wei Li; Dan Luo
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.